Article citationsMore>>

Ward, W.H., Goel, N., Ruth, K.J., Esposito, A.C., Lambreton, F., Sigurdson, E.R., Meyer, J.E. and Farma, J.M. (2018) Predictive Value of Leukocyte-and Platelet-Derived Ratios in Rectal Adenocarcinoma. Journal of Surgical Research, 232, 275-282.
https://doi.org/10.1016/j.jss.2018.06.060

has been cited by the following article:

• TITLE: The Impact of Neutrophil to Lymphocytic Ratio (NLR) as a Predictor of Treatment Outcomes in Rectal Carcinomas: A Retrospective Cohort Study

  AUTHORS: Samir Eid, Hoda Hasan, Doaa Abdel-Aleem, Amal Rayan

  KEYWORDS: Neutrophil to Lymphocyte Ratio, Overall Survival, Disease Free Survival, Rectal Carcinomas

  JOURNAL NAME: Journal of Cancer Therapy, Vol.10 No.9, September 24, 2019

  ABSTRACT: Background and aim: The prognostic role of neutrophil to lymphocyte ratio (NLR) has been shown in many solid tumors included in a recent meta-analysis of one hundred studies. We aimed to evaluate the prognostic value of neutrophil to lymphocyte ratio in treatment outcomes; response and survival of patients with different stages of rectal cancers. Patients and methods: All patients with pathologically confirmed cancer rectum presented to our department during the period from January 2012 to the end of 2014 were included in this retrospective study, these recruited patients were evaluated through their files to determine different objectives of our study. Results: The median overall survival was 31 ± 4.676 months while disease free survival was 40 ± 2.346 for the whole study group; neutrophil to lymphocyte ratio was negatively correlated with overall survival with r = –0.743, P disease free survival with r = –0.717, P total number of lymph nodes dissected ratio with r = +0.254, P = 0.028. Roc curve was used to find the accurate cut point of NLR for these patients and was found to be of 4.5. Conclusion: Elevated pre-treatment NLR is an independent predictor of shorter survival in patients with rectal cancer. This parameter is a simple, easily accessible laboratory test for identifying patients with poorer prognosis.